The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of MAPK signaling subtypes with prognostic benefit for bevacizumab in left-sided metastatic colorectal cancer (mCRC) patients treated with FOLFIRI + cetuximab / bevacizumab (FIRE-3 trial).
 
Arndt Stahler
No Relationships to Disclose
 
Sebastian Stintzing
Honoraria - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Lilly; Merck KGaA; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical; Takeda
 
Dominik Paul Modest
Honoraria - Amgen; Bristol-Myers Squibb; Merck Serono; Pfizer; Roche; SERVIER; Sirtex Medical
Consulting or Advisory Role - Amgen; Bayer; Merck Serono
Research Funding - Amgen (Inst); Merck Serono (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Merck Serono; SERVIER
 
Ivan Jelas
No Relationships to Disclose
 
Kathrin Heinrich
No Relationships to Disclose
 
Lisa Miller-Phillips
No Relationships to Disclose
 
Jobst C. von Einem
No Relationships to Disclose
 
Ursula Vehling-Kaiser
Consulting or Advisory Role - Abbvie; Amgen; Gilead Sciences; Hexal; Lilly; Roche
Speakers' Bureau - Abbvie; Amgen; Boehringer Ingelheim; CSL Behring; Forum for Medical Futher Education; Gilead Sciences; Hexal; Jürgen Schaaf Verlags; Lilly; Merck Serono; Merck Sharp & Dohme; MorphoSys; Octapharm; OnkoInform; Roche; Sirtex Medical
 
Thomas Decker
Consulting or Advisory Role - Novartis
 
Alexander Kiani
No Relationships to Disclose
 
Ludwig Fischer von Weikersthal
No Relationships to Disclose
 
Tobias Heintges
No Relationships to Disclose
 
Christoph Kahl
No Relationships to Disclose
 
Frank Kullmann
No Relationships to Disclose
 
Werner Scheithauer
No Relationships to Disclose
 
Markus H. Moehler
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly/ImClone; Merck Serono; MSD Oncology; Roche/Genentech; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; MSD; Nordic Group; Pfizer; Roche; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Jennerex (Inst); Leap Therapeutics (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; German Cancer Society; Merck Serono; Nordic Bioscience; Roche
 
Pratyaksha Wirapati
No Relationships to Disclose
 
Thomas Kirchner
No Relationships to Disclose
 
Andreas Jung
No Relationships to Disclose
 
Volker Heinemann
Honoraria - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Halozyme; Merck; MSD; Roche; Sanofi; SERVIER; Sirtex Medical
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Roche (Inst); Shire (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER; Shire; Sirtex Medical